Home
About
Overview
Sharing Data
ORCID
Help
History (26)
The validity of risk assessment instruments for transition-age youth.
MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.
Shared Medication PLanning In Home Hospice to Address Medication Regimen Complexity and Family Caregiver Burden: A Brief Report.
Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet.
Chronic myeloproliferative disorder with ETV6-PDGFR? fusion gene.
See All 26 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic myeloproliferative disorder with ETV6-PDGFR? fusion gene.
Tipirneni E, Buttar A, Brettler D, Miron P, Bathini V. Chronic myeloproliferative disorder with ETV6-PDGFR? fusion gene. Ann Hematol. 2012 Apr; 91(4):637-8.
View in:
PubMed
subject areas
Antineoplastic Agents
Benzamides
Female
Humans
Imatinib Mesylate
Middle Aged
Myeloproliferative Disorders
Piperazines
Proto-Oncogene Proteins c-ets
Pyrimidines
Receptor, Platelet-Derived Growth Factor beta
Recombinant Fusion Proteins
Repressor Proteins
authors with profiles
Venu G Bathini MD
Patricia M Miron PhD
Doreen Brettler MD